Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
Website:
http://www.conduitpharma.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 16 Sep 2024 20:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
Similar companies
What type of business is Conduit Pharmaceuticals?
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
What sector is Conduit Pharmaceuticals in?
Conduit Pharmaceuticals is in the Healthcare sector
What industry is Conduit Pharmaceuticals in?
Conduit Pharmaceuticals is in the Biotechnology industry
What country is Conduit Pharmaceuticals from?
Conduit Pharmaceuticals is headquartered in United States
What is Conduit Pharmaceuticals website?
https://www.conduitpharma.com
Is Conduit Pharmaceuticals in the S&P 500?
No, Conduit Pharmaceuticals is not included in the S&P 500 index
Is Conduit Pharmaceuticals in the NASDAQ 100?
No, Conduit Pharmaceuticals is not included in the NASDAQ 100 index
Is Conduit Pharmaceuticals in the Dow Jones?
No, Conduit Pharmaceuticals is not included in the Dow Jones index
When was Conduit Pharmaceuticals the previous earnings report?
No data
When does Conduit Pharmaceuticals earnings report?
Next earnings report date is not announced yet